For our clients interest, we keep part of detailed report due 1-2 weeks from now on before release.
The least we can say, it is about time to sell short ASII on technical wise and as price has also topped valuation on consensus. Our previous target price is well maintained. The most and only profitable trade setup with high probability and low risk for this stock then is simply to sell short this stock, nothing else. While, we poise to sell short this group large cap, we stay positive to take a long side on its group smaller cap. Outside Astra, we also still maintain long, among other, on defensive consumer pharma along, in anticipation of limited market average upside projected this July. '+'
